S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
Log in

Nutrien Stock Price, Forecast & Analysis (NYSE:NTR)

$49.45
+0.52 (+1.06 %)
(As of 11/13/2019 04:00 PM ET)
Today's Range
$48.43
Now: $49.45
$49.54
50-Day Range
$47.84
MA: $49.22
$50.89
52-Week Range
$43.96
Now: $49.45
$56.00
Volume1.19 million shs
Average Volume1.52 million shs
Market Capitalization$28.33 billion
P/E Ratio18.38
Dividend Yield3.68%
Beta0.9
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations. Read More…

Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
Phone306-933-8500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.64 billion
Cash Flow$5.38 per share
Book Value$39.87 per share

Profitability

Net Income$3.57 billion

Miscellaneous

Employees20,300
Market Cap$28.33 billion
Next Earnings Date2/5/2020 (Estimated)
OptionableOptionable

Receive NTR News and Ratings via Email

Sign-up to receive the latest news and ratings for NTR and its competitors with MarketBeat's FREE daily newsletter.


Nutrien (NYSE:NTR) Frequently Asked Questions

What is Nutrien's stock symbol?

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

How often does Nutrien pay dividends? What is the dividend yield for Nutrien?

Nutrien announced a quarterly dividend on Tuesday, July 30th. Investors of record on Monday, September 30th will be paid a dividend of $0.45 per share on Thursday, October 17th. This represents a $1.80 annualized dividend and a yield of 3.64%. The ex-dividend date is Friday, September 27th. This is a boost from Nutrien's previous quarterly dividend of $0.43. View Nutrien's Dividend History.

How were Nutrien's earnings last quarter?

Nutrien Ltd (NYSE:NTR) posted its quarterly earnings results on Monday, November, 4th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.36 by $0.12. The firm earned $4.13 billion during the quarter, compared to the consensus estimate of $4.02 billion. Nutrien had a net margin of 20.95% and a return on equity of 6.49%. The company's quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.47 EPS. View Nutrien's Earnings History.

When is Nutrien's next earnings date?

Nutrien is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Nutrien.

What price target have analysts set for NTR?

15 equities research analysts have issued 12 month price objectives for Nutrien's shares. Their forecasts range from $50.00 to $70.00. On average, they anticipate Nutrien's stock price to reach $61.00 in the next twelve months. This suggests a possible upside of 23.4% from the stock's current price. View Analyst Price Targets for Nutrien.

What is the consensus analysts' recommendation for Nutrien?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 4 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nutrien.

Has Nutrien been receiving favorable news coverage?

Media stories about NTR stock have been trending very negative on Wednesday, according to InfoTrie. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Nutrien earned a news impact score of -3.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Nutrien.

Are investors shorting Nutrien?

Nutrien saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 4,980,000 shares, an increase of 6.0% from the August 30th total of 4,700,000 shares. Based on an average daily volume of 1,350,000 shares, the short-interest ratio is presently 3.7 days. Currently, 0.9% of the company's stock are sold short. View Nutrien's Current Options Chain.

Who are some of Nutrien's key competitors?

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Cimarex Energy (XEC), General Electric (GE), JPMorgan Chase & Co. (JPM), Micron Technology (MU), Verizon Communications (VZ), CVS Health (CVS), Cisco Systems (CSCO), Wells Fargo & Co (WFC) and Intel (INTC).

Who are Nutrien's key executives?

Nutrien's management team includes the folowing people:
  • Mr. Charles Victor Magro B.Sc. (Chem), MBA, Pres, CEO & Exec. Director (Age 49)
  • Mr. Frederick R. Thun, Sr. VP of Fin.
  • Mr. Michael J. Frank, Exec. VP & CEO of Retail (Age 55)
  • Mr. Pedro Farah, Exec. VP & CFO
  • Mr. Brent D. Poohkay, Exec. VP & Chief Information Officer (Age 49)

Who are Nutrien's major shareholders?

Nutrien's stock is owned by many different of retail and institutional investors. Top institutional investors include Beutel Goodman & Co Ltd. (2.30%), CIBC Asset Management Inc (1.25%), Great West Life Assurance Co. Can (0.96%), Cambiar Investors LLC (0.48%), Sumitomo Mitsui Trust Holdings Inc. (0.43%) and Letko Brosseau & Associates Inc. (0.25%).

Which institutional investors are selling Nutrien stock?

NTR stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Beutel Goodman & Co Ltd., Addenda Capital Inc., CWM LLC, QV Investors Inc., Russell Investments Group Ltd., Tocqueville Asset Management L.P. and Sumitomo Mitsui Trust Holdings Inc..

Which institutional investors are buying Nutrien stock?

NTR stock was bought by a variety of institutional investors in the last quarter, including TIAA FSB, Great West Life Assurance Co. Can, Alberta Investment Management Corp, Zurcher Kantonalbank Zurich Cantonalbank, Massachusetts Financial Services Co. MA, ARGA Investment Management LP, Tower Research Capital LLC TRC and BBVA USA Bancshares Inc..

How do I buy shares of Nutrien?

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Nutrien's stock price today?

One share of NTR stock can currently be purchased for approximately $49.45.

How big of a company is Nutrien?

Nutrien has a market capitalization of $28.33 billion and generates $19.64 billion in revenue each year. The company earns $3.57 billion in net income (profit) each year or $2.69 on an earnings per share basis. Nutrien employs 20,300 workers across the globe.View Additional Information About Nutrien.

What is Nutrien's official website?

The official website for Nutrien is http://www.nutrien.com/.

How can I contact Nutrien?

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]


MarketBeat Community Rating for Nutrien (NYSE NTR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  259 (Vote Outperform)
Underperform Votes:  235 (Vote Underperform)
Total Votes:  494
MarketBeat's community ratings are surveys of what our community members think about Nutrien and other stocks. Vote "Outperform" if you believe NTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NTR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel